These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35911748)

  • 1. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
    Clavarino G; Leroy C; Epaulard O; Raskovalova T; Vilotitch A; Pernollet M; Dumestre-Pérard C; Defendi F; Le Maréchal M; Le Gouellec A; Audoin P; Bosson JL; Poignard P; Roustit M; Jacob MC; Cesbron JY
    Front Immunol; 2022; 13():889813. PubMed ID: 35911748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients.
    Kandeel EZ; Refaat L; Bayoumi A; Nooh HA; Hammad R; Khafagy M; Abdellateif MS
    Viral Immunol; 2022 Sep; 35(7):491-502. PubMed ID: 35930238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India.
    Suryawanshi P; Takbhate B; Athavale P; Jali P; Memane N; Mirza S; Karandikar M; Kakrani AL; Kanitkar S; Gandham N; Barthwal MS; Dole S; Chaturvedi S; Pawale S; Tripathy A; Bhawalkar JS; Tripathy S
    Viral Immunol; 2023 Apr; 36(3):163-175. PubMed ID: 36897333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
    Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
    J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and immunological characteristics of COVID-19 patients with delayed SARS-CoV-2 virus clearance.
    Wang J; Li D; Tang B; Sun X; Shi W; Li H; Zhang Z; Wu Y; Zhang Y; Qiao Q
    Immun Inflamm Dis; 2023 Sep; 11(9):e999. PubMed ID: 37773701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
    Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
    Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
    Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
    Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte Subsets in Defense Against New Pathogens in Patients with Cancer.
    Arango-Prado MDC; Villegas-Valverde CA; Torres-López G; Soto-Pardeiro P; Suárez-Reyes A; Faxas-García ME; Diéguez-Rodríguez V; Gracia-Medina E; Esperón-Noa R; Del Castillo-Bahi R; Méndez-Rosabal A; Curbelo-Alfonso L
    MEDICC Rev; 2022 May; 24(2):26-34. PubMed ID: 35648060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.
    Cantenys-Molina S; Fernández-Cruz E; Francos P; Lopez Bernaldo de Quirós JC; Muñoz P; Gil-Herrera J
    Clin Exp Immunol; 2021 Mar; 203(3):424-432. PubMed ID: 33187018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
    He Z; Zhao C; Dong Q; Zhuang H; Song S; Peng G; Dwyer DE
    Int J Infect Dis; 2005 Nov; 9(6):323-30. PubMed ID: 16095942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
    Gupta S; Su H; Agrawal S
    Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.